Hostname: page-component-6dbcb7884d-q4sxc Total loading time: 0 Render date: 2025-02-13T22:41:53.164Z Has data issue: false hasContentIssue false
  • English
  • Français

Toxic interactions between lithium and non-steroidal anti-inflammatory drugs1

Published online by Cambridge University Press:  09 July 2009

George Stein ,
Mary Robertson  and
Jayasheerie Nadarajah
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Psychological Medicine , Volume 18 , Issue 3 , August 1988 , pp. 535 - 543
Copyright
Copyright © Cambridge University Press 1988

References

Abdulla, Y. H. & Hamadah, K. (1975). Effect of ADP on PGE1 formation in blood platelets from patients with depression, mania and schizophrenia. British Journal of Psychiatry 127, 591–595.Google Scholar
Amdisen, A. (1980). Monitoring lithium dose levels: clinical aspects of serum lithium estimation. In Handbook of Lithium Therapy (ed. Johnson, F. N.), pp. 179–195. MTP Press: Lancaster.Google Scholar
Bendz, H. (1983). Kidney function in lithium treated patients. Acta Psychiatrica Scandinavica 68, 303–324.CrossRefGoogle ScholarPubMed
Bendz, H. & Feinberg, M. (1984). Aspirin increases serum lithium ion levels. Archives of General Psychiatry 41, 310–311.CrossRefGoogle ScholarPubMed
Blackwell, B. (1976). Treatment adherence. British Journal of Psychiatry 129, 513–531.Google Scholar
Brezin, J. H., Katz, S. M., Schwartz, A. B., Chinitz, J. L. (1979). Reversible renal failure and nephrotic syndrome associated with nonsteroidal anti-inflammatory drugs. New England Journal of Medicine 301, 1271–1273.CrossRefGoogle ScholarPubMed
Caldwell, H. C., Westlake, W. J., Connor, B. S. & Flanagan, T. (1971). A pharmacokinetic analysis of lithium carbonate absorption from several formations in man. Journal of Clinical Pharmacology 11, 349–356.Google ScholarPubMed
Cohen, W. J. & Cohen, N. H. (1974). Lithium carbonate haloperidol, and irreversible brain damage. Journal of the American Medical Association 230, 1283–1287.Google Scholar
Coppen, A., Bailey, J. E. & White, S. G. (1969). Slow-release lithium carbonate. Journal of Clinical Pharmacology 9, 160–162.Google Scholar
Crammer, J. L., Rosser, R. M. & Crane, G. (1974). Blood levels and management of lithium treatment. British Medical Journal iii, 650–654.Google Scholar
Donker, A. J. M., Arisz, L., Brentjens, J. R. H., Van der Hem, G. K. & Hollemans, H. J. G. (1976). The effect of Indomethacin on kidney function and plasma renin activity in man. Nephron 17, 288–296.CrossRefGoogle ScholarPubMed
Feldberg, (1976). Possible association of schizophrenia with a disturbance in prostaglandin metabolism. A physiological hypothesis. Psychological Medicine 16, 359–369.Google Scholar
Flower, R. J., Moncada, S. & Vane, J. R. (1985). Analgesic—antipyretics and anti-inflammatory agents; drugs employed in the treatment of gout. In The Pharmacological Basis of Therapeutics, 7th edn (eds. Gilman, G., Goodman, L. S. and Rall, T. W.), pp. 674–715.Google Scholar
Frais, M. A., Burgess, E. D. & Mitchell, L. B. (1983). Piroxicam-induced renal failure and hyperkalaemia. Annals of Internal Medicine 99, 129–130.CrossRefGoogle Scholar
Frohlich, J. C., Leftwich, R., Ragheb, M., Oates, J. A., Reimann, I. & Buchanan, D. (1979). Indomethacin increases plasma lithium. British Medical Journal i, 1115–1116.Google Scholar
Fry, D. E. & Marks, V. (1971). Value of plasma-lithium monitoring. Lancet i, 886–888.Google Scholar
Galler, M., Folkert, V. W. & Schlondorff, D. (1981). Reversible acute renal insufficiency and hyperkalaemia following indomethacin therapy. Journal of the Americal Medical Association 246, 154–155.CrossRefGoogle ScholarPubMed
Gross, H. A., Dunner, D. L., La Fleur, D., Meltzer, H. & Fieve, R. R. (1977). Prostaglandin F in patients with affective disorder. Biological Psychiatry 12, 347–357.Google ScholarPubMed
Haghfelt, T., Lund, J. O. & Jorgensen, H. E. (1971). Lithium forgiftning og nyrefunction. Nordisck Medicin 12, 1465–14711.Google Scholar
Hansen, H. E. & Amdisen, A. (1978). Lithium intoxication (report of 23 cases and a review of 100 cases from the literature). Quarterly Journal of Medicine. New Series 47, 123–144.Google Scholar
Hansen, H. E., Hestbeck, J., Sorensen, J. L., Norgaard, K., Heilskov, J. & Amdisen, A. (1979). Chronic interstitial nephropathy in patients on long-term lithium treatment. Quarterly Journal of Medicine 48, 577–591.Google Scholar
Hierschberg, S. N. and Sierles, F. S. (1983). Indomethacin induced lithium toxicity. American Family Physician 28 (2), 155–157.Google Scholar
Imbs, J. L., Danion, J. M., Serban, M., Belhadi-Mostefa, M. & Schmidt et Singer, L. (1978). Influence des anti-inflammatoires sur la réabsorption tubulaire du lithium. Journal of Pharmacology 9, 171–172.Google Scholar
Kafka, M. S. and Van Kammen, D. P. & Bunney, W. E. (1979). Reduced cyclic AMP in the blood platelets from schizophrenic patients. American Journal of Psychiatry 136, 685–687.Google Scholar
Kanof, P. D., Johns, C., Davidson, M., Siever, L., Coccaro, E. F. & Davis, K. L. (1986). Prostaglandin sensitivity in psychiatric disorders. Archives of General Psychiatry 43, 987–993.CrossRefGoogle ScholarPubMed
Kerry, R. J., Owen, G. & Michaelson, S. (1983). Possible toxic interaction between lithium and piroxicam. Lancet i, 418–419.CrossRefGoogle Scholar
Kimberley, R. P., Bowden, R. E., Keiser, H. R. & Plotz, P. H. (1978). Reduction of renal function by new non-steroidal anti-inflammatory drugs. American Journal of Medicine 64, 804–807.Google Scholar
Krupp, P. & Wesp, , (1975). Psychotropic drugs and prostaglandin synthesis in bovine seminal vesicles. Experentia 31, 330.Google Scholar
Lassen, E., Vestergaard, P. & Thomsen, K. (1986). Renal function of patients in long-term treatment with lithium citrate alone or in combination with neuroleptics and antidepressant drugs. Archives of General Psychiatry 43, 481–482.Google Scholar
Lee, R. E. (1974). Prostaglandin synthesis and psychotropic drugs in the guinea-pig lung. Prostaglandins 5, 63–00.Google Scholar
Leftwich, R., Walker, L. & Smigel, M. (1977). Indomethacin is antidiuretic in lithium-induced diabetes insipidus. Clinical Research 25, 272A.Google Scholar
McCreadie, R. G. & Morrison, D. P. (1985). The impact of lithium in south-west Scotland. I. Demographic and clinical findings. British Journal of Psychiatry 146, 70–80.CrossRefGoogle ScholarPubMed
Moskovitz, R., Springer, P. & Urquhart, M. (1981). Lithium-induced nephrotic syndrome. American Journal of Psychiatry 138, 382–383.Google ScholarPubMed
Mtabaji, J., Robinson, C. J., Mankum, M. S., Cronia, D. & Horrobin, D. F. (1977). Prostaglandin A2 at low infusion rates restores the anti-diuretic effect of vasopressin in lithium treated rats. Journal of Endocrinology 73, 31–36.CrossRefGoogle Scholar
Murphy, D. L., Donnelly, C. & Moskowitz, J. (1973). Inhibition by lithium of prostaglandin E1 and norepinephrine effects on cyclic adenosine monophosphate production in human platelets. Clinical Pharmacology and Therapeutics 14, 810–814.Google Scholar
Nadarajah, J. & Stein, G. S. (1985). Piroxicam induced lithium toxicity. Annals of Rheumatic Diseases 44, 502.Google Scholar
Overview (1986). Side effects of anti-inflammatory drugs. An overview from the Second International Meeting, Queens College, Cambridge, 1985. Rheumatology in Practice 13–15.Google Scholar
Raftery, J., Forman, P., Farrington, K., Sweny, P. & Moorhead, J. F. (1985). Fenclofenac induced interstitial nephritis confirmed by inadvertent rechallenge. British Medical Journal 290, 1178–1179.Google Scholar
Ragheb, M., Ban, T. A., Buchanan, D. & Frohlich, J. C. (1980). Interaction of indomethacin and ibuprofen with lithium in manic patients under a steady state lithium level. Journal of Clinical Psychiatry 41, 397–398.Google Scholar
Reimann, I. W. & Frohlich, J. C. (1981). Effects of diclofenac on lithium kinetics. Clinical Pharmacology and Therapeutics 30, 348–352.Google Scholar
Reimann, I. W., Diener, U. & Frohlich, J. C. (1983). Indomethacin but not aspirin increases plasma lithium ion levels. Archives of General Psychiatry 40, 283–286.Google Scholar
Rotrosen, J., Miller, A. D., Mandio, L. J., Trafficante, L. J. & Gershon, S. (1980). Effects of ethanol and Prostaglandin E1, biochemical and behavioural interactions. Life Sciences 26, 1867–1876.CrossRefGoogle Scholar
Rotrosen, J., Miller, A. D., Mandio, L. D., Trafficante, L. J. & Gershon, S. (1980). Prostaglandins, platelets and schizophrenia. Archives of General Psychiatry 37, 1047–1064.CrossRefGoogle ScholarPubMed
Schaeffer, A., Komlos, M. & Seregi, A. (1978). Effects of biogenic amines and psychotropic drugs on endogenous prostaglandin biosynthesis in the rat brain homogenates. Biochemical Pharmacology 27, 213–218.CrossRefGoogle Scholar
Shelley, R. K. (1986). Lithium and piroxicam. British Journal of Psychiatry 148, 343.Google Scholar
Sletten, I., Pichardo, J., Korol, B. & Gershon, S. (1966). The effect of chlorpromazine on lithium excretion in psychiatric subjects. Current Therapeutic Research 8, 441–446.Google Scholar
Stokes, J. B. & Kokko, J. P. (1977). Inhibition of sodium transport by prostaglandin E2 across the isolated perfused rabbit collecting tubule. Journal of Clinical Investigation 59, 1099–1104.Google Scholar
Tan, S. R., Shapiro, R., Franco, R., Stockhard, H. & Mulrow, P. J. (1979). Indomethacin-induced prostaglandin inhibition with hyperkalaemia: a reversible cause of hyporeninemic hypoaldosteronism. Annals of Internal Medicine 90, 783–785.Google Scholar
Tyrer, S., Hullin, R. P., Birch, N. J. & Goodwin, J. C. (1976). Absorption of lithium following administration of slow-release and conventional preparations. Psychological Medicine 6, 51–58.Google Scholar
Vrhovac, B. (1984). Anti-inflammatory analgesics and drugs used in gout. In Meyler's Side Effect of Drugs, 10th edn (ed. Dukes, M. N. G.), pp. 151–182. Elsevier: Amsterdam.Google Scholar
Walbridge, D. G. & Bazire, S. R. (1985). An interaction between lithium carbonate and piroxicam presenting as lithium toxicity. British Journal of Psychiatry 147, 206–207.Google Scholar
Walker, R. G., Bennett, W. M., Davies, B. M. & Kincaid Smith, P. (1982). Structural and functional effects of long term lithium therapy. Kidney International 21, Suppl. 11, 513–519.Google Scholar
Wang, Y. C., Pandey, G. N., Mendels, J. & Frazer, A. (1974). Effect of prostaglandin E1-stimulated adenylate cyclase activity of human platelets. Biochemical Pharmacology 23, 845–855.Google Scholar
Weir, J. G. (1973) Serum lithium estimations. British Medical Journal i, 356–357.Google Scholar
Wendland, M. L., Wagoner, R. D., Hollay, K. E. (1980). Renal failure associated with fenoprofen. Mayo Clinic Proceedings 55, 103–107.Google ScholarPubMed
Wiseman, E. H. & Boyle, J. A. (1980). Piroxicam (Feldene). Clinics in Rheumatic Diseases 6, 585–613.CrossRefGoogle Scholar